Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28614
Title: | BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer |
Authors: | Uludağ Üniversitesi/Sağlık Meslek Yükseokulu/Tıbbi Laboratuvar Teknikleri Programı. Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı. 0000-0001-7668-796X 0000-0002-3820-424X 0000-0002-5956-8755 0000-0001-7904-883X 0000-0002-1619-6680 0000-0003-1394-2630 0000-0002-9038-0515 Ertürk, Elif Çeçener, Gülşah Tezcan, Gülçin Egeli, Ünal Tunca, Berrin Gökgöz, Şehsuvar Tolunay, Şahsine Taşdelen, İsmet AAK-3371-2021 AAP-9988-2020 AAH-3843-2020 AAH-1420-2021 ABI-6078-2020 EXK-4525-2022 AAI-1612-2021 EBN-1186-2022 50261655300 6508156530 25650627600 55665145000 6602965754 6603238737 6602604390 9637821500 |
Keywords: | BRCA1/2 gene mutations MicroRNA MiR-200c Triple negative breast cancer Epithelial-mesenchymal transition Down-regulation Ovarian-cancer Feedback loop Family Zeb1 MicroRNA-200c Progression Metastasis Resistance |
Issue Date: | 10-Feb-2015 |
Publisher: | Elsevier |
Citation: | Ertürk, E. vd. (2015). "BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer". Gene, 556(2), 163-169. |
Abstract: | Triple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs. |
URI: | https://doi.org/10.1016/j.gene.2014.11.047 https://www.sciencedirect.com/science/article/pii/S0378111914013249 http://hdl.handle.net/11452/28614 |
ISSN: | 0378-1119 1879-0038 |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.